Argenx Se (ARGX) Non Operating Interest Expenses (2019 - 2026)
Powered by 
Analysis
Argenx Se (ARGX) Non Operating Interest Expenses (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.68 Bn | 131.82 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.68 Bn | 77.68 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.67 Bn | 58.48 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 57.02 Bn | 51.88 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.83 Bn | 43.83 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 39.97 Bn | 34.87 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.23 Bn | 31.93 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.56 Bn | 27.72 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn | 582,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.00 Mn |
| Mar 31, 2026 | -1.00 Mn |
| Dec 31, 2025 | -828,000.00 |
| Sep 30, 2025 | -993,000.00 |
| Jun 30, 2025 | -1.13 Mn |
| Mar 31, 2025 | -1.00 Mn |
| Dec 31, 2024 | -704,000.00 |
| Sep 30, 2024 | -676,000.00 |
| Jun 30, 2024 | -572,000.00 |
| Mar 31, 2024 | -512,000.00 |
| Dec 31, 2023 | -280,000.00 |
| Sep 30, 2023 | -231,000.00 |
| Jun 30, 2023 | -207,000.00 |
| Mar 31, 2023 | -188,000.00 |
| Dec 31, 2022 | -990,000.00 |
| Sep 30, 2022 | -785,000.00 |
| Jun 30, 2022 | -1.18 Mn |
| Mar 31, 2022 | -953,000.00 |
| Dec 31, 2021 | -1.10 Mn |
| Sep 30, 2021 | -1.10 Mn |